Medication info

Mefoglitin Tablets 5 mg (Linagliptin)

Prescription medicationTabletExpired
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Bright red, round film-coated tablet with a convex shape on both sides and sharp edges.
Packaging
30 tablets/PTP [(10 tablets/PTP × 3)]
Approval status
Expired

MFDS item code 201907799 · Approved 2019.11.07

This product's status changed to Expired on 2024.11.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 5 mg once daily. It may be administered regardless of meals. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), lower doses of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes.
View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be administered alone to patients starting treatment, and if monotherapy is insufficient, it may be used in combination with metformin. Furthermore, it is combined when blood sugar is not controlled with either metformin or sulfonylurea monotherapy. This medication can also be added when blood sugar control is inadequate during insulin therapy, and it is combined when the combination of sulfonylurea and metformin is ineffective. It is used when blood sugar control remains a challenge after combination therapy with empagliflozin and metformin. In summary, this medication is used to improve blood sugar control in conjunction with various diabetes treatment regimens.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 5 mg once daily. It may be administered regardless of meals. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), lower doses of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Precautions

This medication should not be used in individuals with allergies to the active ingredient or other components. It is also safe not to administer it to patients with type 1 diabetes or diabetic ketoacidosis. Caution is required when used with other medications that can cause hypoglycemia. In particular, when taken with insulin or sulfonylurea medications, the risk of hypoglycemia may increase, necessitating dosage adjustments. In patients with mild to moderate heart failure, this drug should be used cautiously; it is not recommended in severe cases. Acute pancreatitis may occur during the use of this medication, so if severe abdominal pain persists, discontinue use immediately and consult a physician. A blistering skin condition resembling pemphigus may appear, so if any skin abnormality develops, stop taking the medication and consult a specialist. Symptoms of hypoglycemia may occur while taking this medication, so appropriate action should be taken immediately if symptoms arise. Pregnant or nursing women are advised to avoid using this medication, especially since safety has not been established for pregnant women. It is not advisable to use this medication in children and adolescents, particularly in those under 10 years of age. Elderly patients can use this medication safely without specific dosage adjustments. Patients with poor kidney or liver function can also use this medication without dosage adjustments, but must follow a physician's instructions. In cases of overdose, unabsorbed medication should be removed from the gastrointestinal tract, and symptoms should be monitored while receiving necessary treatment. This medication should be stored out of reach of children, and transferring it to another container is not advisable for quality maintenance and safety reasons.

Side effects

Hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is best to store at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Bright red, round film-coated tablet with a convex shape on both sides and sharp edges.

Package unit

30 tablets/PTP [(10 tablets/PTP × 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.